Prospective evaluation of concomitant lymphadenectomy in robot-assisted radical prostatectomy: Preliminary analysis of outcomes

Fatih Atug, Erik P Castle, Sudesh K. Srivastav, Scott V. Burgess, Raju Thomas, Rodney Davis

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Background and Purpose: Lymph-node staging is important in many patients with prostate cancer, as it influences adjuvant treatment and prognosis. However, lymphadenectomy adds to the operating time, cost, and potential for complications. Herein, we compared the effects of concomitant lymphadenectomy in patients undergoing robot-assisted radical prostatectomy (RARP). Patients and Methods: Data were collected prospectively on 145 consecutive RARPs. Patients were evaluated in two groups. Group I was patients who underwent RARP and concomitant lymphadenectomy (LAD)(N = 40), and group II consisted of patients who underwent RARP only (N = 105). Operative time (OT), length of hospital stay (LOS), estimated blood loss (EBL), cost, and complications were compared in the two groups. Results: The mean number of lymph nodes removed per patient in group I was 14.08 (range 9-24). Lymphnode metastases were detected in 2 (5%) of the patients. There were no statistically significant differences in LOS, EBL, OT, operative charges, or hospital charges in the two groups. However, the mean OT increased 9.3% when LAD was performed. At a mean follow-up of 14.8 months (range 3-32 months), 16 complications had been observed in the entire series of patients (11.03%). According to the Clavien system, there were eight grade I complications, seven grade II complications, and one grade III complication. Four complications occurred in group I (10%) and 12 in group II (11.4%). There were no lymphoceles or deep venous thromboses (DVTs) in group I. Cost analysis showed no statistically significant difference between the groups. Conclusion: There was no significant impact of concomitant lymphadenectomy on LOS, EBL, charges, or complications when RARP was performed. Although the difference was not statistically significant, the OT will be slightly longer, as an additional procedure is being performed.

Original languageEnglish (US)
Pages (from-to)514-518
Number of pages5
JournalJournal of Endourology
Volume20
Issue number7
DOIs
StatePublished - Jul 2006
Externally publishedYes

Fingerprint

Prostatectomy
Lymph Node Excision
Length of Stay
Operative Time
Costs and Cost Analysis
Lymph Nodes
Lymphocele
Hospital Charges
Venous Thrombosis
Prostatic Neoplasms
Neoplasm Metastasis

ASJC Scopus subject areas

  • Urology

Cite this

Prospective evaluation of concomitant lymphadenectomy in robot-assisted radical prostatectomy : Preliminary analysis of outcomes. / Atug, Fatih; Castle, Erik P; Srivastav, Sudesh K.; Burgess, Scott V.; Thomas, Raju; Davis, Rodney.

In: Journal of Endourology, Vol. 20, No. 7, 07.2006, p. 514-518.

Research output: Contribution to journalArticle

Atug, Fatih ; Castle, Erik P ; Srivastav, Sudesh K. ; Burgess, Scott V. ; Thomas, Raju ; Davis, Rodney. / Prospective evaluation of concomitant lymphadenectomy in robot-assisted radical prostatectomy : Preliminary analysis of outcomes. In: Journal of Endourology. 2006 ; Vol. 20, No. 7. pp. 514-518.
@article{614a421c4d36455bb91877c1efe3fc0e,
title = "Prospective evaluation of concomitant lymphadenectomy in robot-assisted radical prostatectomy: Preliminary analysis of outcomes",
abstract = "Background and Purpose: Lymph-node staging is important in many patients with prostate cancer, as it influences adjuvant treatment and prognosis. However, lymphadenectomy adds to the operating time, cost, and potential for complications. Herein, we compared the effects of concomitant lymphadenectomy in patients undergoing robot-assisted radical prostatectomy (RARP). Patients and Methods: Data were collected prospectively on 145 consecutive RARPs. Patients were evaluated in two groups. Group I was patients who underwent RARP and concomitant lymphadenectomy (LAD)(N = 40), and group II consisted of patients who underwent RARP only (N = 105). Operative time (OT), length of hospital stay (LOS), estimated blood loss (EBL), cost, and complications were compared in the two groups. Results: The mean number of lymph nodes removed per patient in group I was 14.08 (range 9-24). Lymphnode metastases were detected in 2 (5{\%}) of the patients. There were no statistically significant differences in LOS, EBL, OT, operative charges, or hospital charges in the two groups. However, the mean OT increased 9.3{\%} when LAD was performed. At a mean follow-up of 14.8 months (range 3-32 months), 16 complications had been observed in the entire series of patients (11.03{\%}). According to the Clavien system, there were eight grade I complications, seven grade II complications, and one grade III complication. Four complications occurred in group I (10{\%}) and 12 in group II (11.4{\%}). There were no lymphoceles or deep venous thromboses (DVTs) in group I. Cost analysis showed no statistically significant difference between the groups. Conclusion: There was no significant impact of concomitant lymphadenectomy on LOS, EBL, charges, or complications when RARP was performed. Although the difference was not statistically significant, the OT will be slightly longer, as an additional procedure is being performed.",
author = "Fatih Atug and Castle, {Erik P} and Srivastav, {Sudesh K.} and Burgess, {Scott V.} and Raju Thomas and Rodney Davis",
year = "2006",
month = "7",
doi = "10.1089/end.2006.20.514",
language = "English (US)",
volume = "20",
pages = "514--518",
journal = "Journal of Endourology",
issn = "0892-7790",
publisher = "Mary Ann Liebert Inc.",
number = "7",

}

TY - JOUR

T1 - Prospective evaluation of concomitant lymphadenectomy in robot-assisted radical prostatectomy

T2 - Preliminary analysis of outcomes

AU - Atug, Fatih

AU - Castle, Erik P

AU - Srivastav, Sudesh K.

AU - Burgess, Scott V.

AU - Thomas, Raju

AU - Davis, Rodney

PY - 2006/7

Y1 - 2006/7

N2 - Background and Purpose: Lymph-node staging is important in many patients with prostate cancer, as it influences adjuvant treatment and prognosis. However, lymphadenectomy adds to the operating time, cost, and potential for complications. Herein, we compared the effects of concomitant lymphadenectomy in patients undergoing robot-assisted radical prostatectomy (RARP). Patients and Methods: Data were collected prospectively on 145 consecutive RARPs. Patients were evaluated in two groups. Group I was patients who underwent RARP and concomitant lymphadenectomy (LAD)(N = 40), and group II consisted of patients who underwent RARP only (N = 105). Operative time (OT), length of hospital stay (LOS), estimated blood loss (EBL), cost, and complications were compared in the two groups. Results: The mean number of lymph nodes removed per patient in group I was 14.08 (range 9-24). Lymphnode metastases were detected in 2 (5%) of the patients. There were no statistically significant differences in LOS, EBL, OT, operative charges, or hospital charges in the two groups. However, the mean OT increased 9.3% when LAD was performed. At a mean follow-up of 14.8 months (range 3-32 months), 16 complications had been observed in the entire series of patients (11.03%). According to the Clavien system, there were eight grade I complications, seven grade II complications, and one grade III complication. Four complications occurred in group I (10%) and 12 in group II (11.4%). There were no lymphoceles or deep venous thromboses (DVTs) in group I. Cost analysis showed no statistically significant difference between the groups. Conclusion: There was no significant impact of concomitant lymphadenectomy on LOS, EBL, charges, or complications when RARP was performed. Although the difference was not statistically significant, the OT will be slightly longer, as an additional procedure is being performed.

AB - Background and Purpose: Lymph-node staging is important in many patients with prostate cancer, as it influences adjuvant treatment and prognosis. However, lymphadenectomy adds to the operating time, cost, and potential for complications. Herein, we compared the effects of concomitant lymphadenectomy in patients undergoing robot-assisted radical prostatectomy (RARP). Patients and Methods: Data were collected prospectively on 145 consecutive RARPs. Patients were evaluated in two groups. Group I was patients who underwent RARP and concomitant lymphadenectomy (LAD)(N = 40), and group II consisted of patients who underwent RARP only (N = 105). Operative time (OT), length of hospital stay (LOS), estimated blood loss (EBL), cost, and complications were compared in the two groups. Results: The mean number of lymph nodes removed per patient in group I was 14.08 (range 9-24). Lymphnode metastases were detected in 2 (5%) of the patients. There were no statistically significant differences in LOS, EBL, OT, operative charges, or hospital charges in the two groups. However, the mean OT increased 9.3% when LAD was performed. At a mean follow-up of 14.8 months (range 3-32 months), 16 complications had been observed in the entire series of patients (11.03%). According to the Clavien system, there were eight grade I complications, seven grade II complications, and one grade III complication. Four complications occurred in group I (10%) and 12 in group II (11.4%). There were no lymphoceles or deep venous thromboses (DVTs) in group I. Cost analysis showed no statistically significant difference between the groups. Conclusion: There was no significant impact of concomitant lymphadenectomy on LOS, EBL, charges, or complications when RARP was performed. Although the difference was not statistically significant, the OT will be slightly longer, as an additional procedure is being performed.

UR - http://www.scopus.com/inward/record.url?scp=33746826019&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746826019&partnerID=8YFLogxK

U2 - 10.1089/end.2006.20.514

DO - 10.1089/end.2006.20.514

M3 - Article

C2 - 16859467

AN - SCOPUS:33746826019

VL - 20

SP - 514

EP - 518

JO - Journal of Endourology

JF - Journal of Endourology

SN - 0892-7790

IS - 7

ER -